trending Market Intelligence /marketintelligence/en/news-insights/trending/asmu8utcxdkg5tj-nz0k9g2 content esgSubNav
In This List

IDEXX Laboratories director to retire

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


IDEXX Laboratories director to retire

William End plans to retire as a class I director of IDEXX Laboratories Inc. after the expiration of his term at the company's 2018 annual meeting of stockholders on May 9.

IDEXX's board has decided to reduce the board size to eight directors and lower class I directors to two, effective upon End's retirement.

End has been a board member since 2000. IDEXX said his decision to retire from the board was not the result of any disagreement with the company on any matter relating to the company's operations, policies or practices.